VSCPX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

VSCPX Analyst Rating

Moderate Buy

937 Buy

392 Hold

42 Sell

Based on the consensus analyst ratings on 1,371 stocks held in VSCPX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

VSCPX Analyst Price Target

Average Price Target

$362.74

Based on 1,371 Wall Street analysts offering 12 month price targets to Vanguard Small-Cap Index Fund Insti Plus holdings in the last 3 months. The average price target is $362.74 with a high forecast of $441.41 and a low forecast of $304.99. The average price target represents a 18.30% change from the last price of $306.62.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"290":"$290","328":"$328","366":"$366","404":"$404","442":"$442"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":441.41,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$441.41</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":362.743,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$362.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":304.99,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$304.99</span>\n  </div></div>","useHTML":true}}],"tickPositions":[290,328,366,404,442],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,300.08,310.95153846153846,321.82307692307694,332.69461538461536,343.56615384615384,354.4376923076923,365.3092307692308,376.1807692307692,387.0523076923077,397.92384615384617,408.79538461538465,419.6669230769231,430.53846153846155,{"y":441.41,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,300.08,304.90023076923075,309.7204615384615,314.54069230769227,319.3609230769231,324.18115384615385,329.0013846153846,333.82161538461537,338.64184615384613,343.4620769230769,348.28230769230765,353.1025384615385,357.92276923076923,{"y":362.743,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,300.08,300.4576923076923,300.8353846153846,301.2130769230769,301.59076923076924,301.96846153846155,302.34615384615387,302.7238461538461,303.10153846153844,303.47923076923075,303.85692307692307,304.2346153846154,304.6123076923077,{"y":304.99,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":291.5,"date":1714521600000,"info":"<div>Price: <b>$292<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":300.82,"date":1717372800000,"info":"<div>Price: <b>$301<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":295.87,"date":1719792000000,"info":"<div>Price: <b>$296<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":311.75,"date":1722470400000,"info":"<div>Price: <b>$312<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":311.04,"date":1725321600000,"info":"<div>Price: <b>$311<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":322.22,"date":1727740800000,"info":"<div>Price: <b>$322<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":324.05,"date":1730419200000,"info":"<div>Price: <b>$324<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":356.61,"date":1733097600000,"info":"<div>Price: <b>$357<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":330.64,"date":1735776000000,"info":"<div>Price: <b>$331<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":339.75,"date":1738540800000,"info":"<div>Price: <b>$340<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":319.27,"date":1740960000000,"info":"<div>Price: <b>$319<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":307.77,"date":1743465600000,"info":"<div>Price: <b>$308<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":300.08,"date":1746057600000,"info":"<div>Price: <b>$300<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$441.41

Average Price Target$362.74

Lowest Price Target$304.99

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

VSCPX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

RCKT

Rocket Pharma

15 Buy

1 Hold

0 Sell

Strong Buy

$37.23

xxxxxxxxxxxxxxxxxxxxxxxxxxx

PRME

Prime Medicine, Inc.

6 Buy

3 Hold

0 Sell

Moderate Buy

$9.80

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GETY

Getty Images Holdings Inc

3 Buy

1 Hold

0 Sell

Strong Buy

$11.81

xxxxxxxxxxxxxxxxxxxxxxxxxxx

IOVA

Iovance Biotherapeutics

9 Buy

6 Hold

0 Sell

Moderate Buy

$11.54

xxxxxxxxxxxxxxxxxxxxxxxxxxx

NOVA

Sunnova Energy International

0 Buy

17 Hold

1 Sell

Hold

$1.01

VSCPX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GME

GameStop Corp

0 Buy

0 Hold

1 Sell

Moderate Sell

$13.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

HTZ

Hertz Global Holdings Inc

0 Buy

4 Hold

4 Sell

Moderate Sell

$3.81

xxxxxxxxxxxxxxxxxxxxxxxxxxx

SMR

Nuscale Power Corporation

5 Buy

2 Hold

1 Sell

Moderate Buy

$19.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

CRCT

Cricut, Inc.

0 Buy

1 Hold

3 Sell

Moderate Sell

$3.98

xxxxxxxxxxxxxxxxxxxxxxxxxxx

LFUS

Littelfuse

1 Buy

2 Hold

0 Sell

Moderate Buy

$148.00

VSCPX Mutual Fund FAQ

What is VSCPX’s average 12-month price target, according to analysts?

Based on analyst ratings, Vanguard Small-Cap Index Fund Insti Plus’s 12-month average price target is 362.74.

What is VSCPX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for VSCPX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is VSCPX a Buy, Sell or Hold?

Vanguard Small-Cap Index Fund Insti Plus has a consensus rating of Moderate Buy which is based on 937 buy ratings, 392 hold ratings and 42 sell ratings.

What is Vanguard Small-Cap Index Fund Insti Plus’s price target?

The average price target for Vanguard Small-Cap Index Fund Insti Plus is 362.74. This is based on 1371 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $441.41 ,the lowest forecast is $304.99. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about Vanguard Small-Cap Index Fund Insti Plus?

Vanguard Small-Cap Index Fund Insti Plus’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1371 Wall Streets Analysts.

How can I buy shares of VSCPX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing